Interpace Biosciences, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Health Services » Servicestothe Health Industry
IQVIQVIA Holdings, Inc. -1.61%170.700.0%$161.99m
DGXQuest Diagnostics, Inc. 0.87%124.394.3%$117.94m
LHLaboratory Corp. of America Holdings -0.70%203.772.4%$108.58m
SYNHSyneos Health, Inc. -2.04%58.090.0%$49.50m
IDXGInterpace Biosciences, Inc. 2.39%3.4322.8%$8.31m
NRCNational Research Corp. 0.79%53.250.0%$1.41m
AMEHApollo Medical Holdings, Inc. 2.40%18.330.0%$1.10m
PLXProtalix Biotherapeutics, Inc. -2.99%3.5725.3%$0.26m
PMDPsychemedics Corp. 1.89%4.310.7%$0.11m
BASIBioanalytical Systems, Inc. 0.38%5.360.2%$0.10m

Company Profile

Interpace Biosciences, Inc. operates as an bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment; ThyGenX and PathFinderTG which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay. The company was founded by John P. Dugan in 1987 and is headquartered in Parsippany, NJ.